CLINICAL_TRIALS
research
· 2024-06-13
Clinical Trial Update: mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism
Summary
A planned clinical study from the University of Monastir is investigating whether mRNA expression and DRD3 rs6280 and HTR2A rs6313 polymorphisms are associated …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Monastir | Conditions: Bruxism | Status: NOT_YET_RECRUITING